Development and Funding – NYU GPH Journal of Public Health Disasters

December 13, 2024December 13, 2024

Tuberculosis Re-Emerges as Leading Infectious Disease Killer

Tuberculosis re-emerges as the leading infectious disease killer globally, with reports of approximately 8.2 million people diagnosed in 2024. The significant underfunding of vaccinations and prevention information raises disease prevalence in vulnerable regions. Low and middle-income countries bear the majority of the TB burden; up to 56% of the global TB burden comes from 5 countries: India (26%), Indonesia (10%), China (6.8%), the Philippines (6.8%), and Pakistan (6.3%). While the World Health Organization (WHO) is leading efforts to advance TB vaccines, its research remains underfunded, with only a fifth of the $5 billion goal reached in 2022.

December 5, 2024December 5, 2024

PAHO States Introduce Way to Enhance Early Detection of Health Threats

In October 2024, member states of the Pan American Health Organization (PAHO) gathered to adopt a thorough strategy that strengthens early detection and response to health threats across the Americas. This initiative tackles the vulnerabilities revealed by recent global health crises like the COVID-19 pandemic, drawing attention to the necessity for strong systems that can monitor and respond effectively to new diseases as they arise. Countries without these measures may risk common outbreaks and significant loss of life, with underserved regions being especially affected.

September 7, 2024September 7, 2024

New Study Reveals HIV Preventative Drug With 99% Efficacy

A life-saving HIV preventative drug with nearly 100% efficacy passed its latest round of trials, providing hope to millions worldwide, especially in sub-Saharan Africa, which has one of the highest HIV rates in the world. Although advocates celebrate the arrival of this new drug, many are skeptical that the twice-a-year injection will be made affordable to people in the low-income countries that need it most.